Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
复制标题
DOI:
10.1371/journal.pone.0239871
复制
发表时间:
2020
期刊:
影响因子:
3.7
通讯作者:
Alzheimer’s Disease Neuroimaging Initiative
中科院分区:
文献类型:
--
作者:
Gupta A;Kennedy K;Perales-Puchalt J;Drew D;Beddhu S;Sarnak M;Burns J;Alzheimer’s Disease Neuroimaging Initiative
Chronic kidney disease (CKD) is associated with cognitive impairment and dementia. We examined whether this relationship hold true in older adults, who have a higher prevalence of both CKD and dementia. We conducted a cross-sectional secondary analysis of an established observational cohort. We analyzed data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an NIH funded, multicenter longitudinal observational study, which includes participants with normal and impaired cognition and assesses cognition with a comprehensive battery of neuropsychological tests. We included a non-probability sample of all ADNI participants with serum creatinine measurements at baseline (N = 1181). Using multivariable linear regression analysis, we related the CKD Epidemiology Collaboration equation eGFR with validated composite scores for memory (ADNI-mem) and executive function (ADNI-EF). For the 1181 ADNI participants, the mean age was 73.7 ± 7.1 years. Mean estimated glomerular filtration rate (eGFR) was 76.4 ± 19.7; 6% had eGFR<45, 22% had eGFR of 45 to <60, 51% had eGFR of 60–90 and 21% had eGFR>90 ml/min/1.73 m2. The mean ADNI-Mem score was 0.241 ± 0.874 and mean ADNI-EF score was 0.160 ± 1.026. In separate multivariable linear regression models, adjusted for age, sex, race education and BMI, there was no association between each 10 ml/ min/1.73 m2 higher eGFR and ADNI-Mem (β -0.02, 95% CI -0.04, 0.02, p = 0.56) or ADNI-EF (β 0.01, 95% CI -0.03, 0.05, p = 0.69) scores. We did not observe an association between eGFR and cognition in the older ADNI participants.
登录
查看更多内容
DOI:
10.1053/j.ajkd.2016.11.015
发表时间:
2017-06
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
Drew DA;Weiner DE;Tighiouart H;Duncan S;Gupta A;Scott T;Sarnak MJ
通讯作者:
Sarnak MJ
影响因子:
3.2
作者:
Crane, Paul K.;Carle, Adam;Gibbons, Laura E.;Insel, Philip;Mackin, R. Scott;Gross, Alden;Jones, Richard N.;Mukherjee, Shubhabrata;Curtis, S. McKay;Harvey, Danielle;Weiner, Michael;Mungas, Dan
通讯作者:
Mungas, Dan
DOI:
10.1053/j.ajkd.2009.12.016
发表时间:
2010-04
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
Matsushita K;Selvin E;Bash LD;Astor BC;Coresh J
通讯作者:
Coresh J
影响因子:
13.6
作者:
Fan, Li;Levey, Andrew S.;Inker, Lesley A.
通讯作者:
Inker, Lesley A.
影响因子:
120.7
作者:
Hallan, Stein I.;Matsushita, Kunihiro;Sang, Yingying;Mahmoodi, Bakhtawar K.;Black, Corri;Ishani, Areef;Kleefstra, Nanne;Naimark, David;Roderick, Paul;Tonelli, Marcello;Wetzels, Jack F. M.;Astor, Brad C.;Gansevoort, Ron T.;Levin, Adeera;Wen, Chi-Pang;Coresh, Josef
通讯作者:
Coresh, Josef